Lack of clinically useful response predictors for treating aggression and agitation in Alzheimer's disease with citalopram.
Department of Psychiatry, University of Toronto and Sunnybrook Health Sciences Centre, 2075 Bayview Ave, FG19, Toronto, ON M4N 3M5, Canada; Nathan.herrmann@sunnybrook.ca.
Nathan
N
Herrmann
D000374:Aggression; D000544:Alzheimer Disease / Q000188:drug therapy*; D015283:Citalopram / Q000627:therapeutic use*; D006801:Humans; D011595:Psychomotor Agitation / Q000188:drug therapy
D015283:Citalopram